Home Therapies Inflammatory Bowel Disease

Inflammatory Bowel Disease

in Malaysia

What is Inflammatory Bowel Disease?

Inflammatory bowel disease is an immune-mediated disease. It arises due to a complex interplay between a patient’s genetics and environmental factors that cause the patient’s immune system to mount inappropriate responses to intestinal microbes. Inflammatory bowel disease usually includes Crohn’s disease and ulcerative colitis. These are relapsing and remitting conditions characterised by chronic inflammation and lesions at various… More

wjMSCs Treat Inflammatory Bowel Disease by

01Decreasing colitis, diarrhoea frequency, abdominal pain and cramps, and activity and severity indices,
02Increasing body weight,
03Achieving and maintaining long-lasting clinical-endoscopic remission,
04Draining, closing, and decreasing the size of fistulas,
05Significantly decreasing rough mucosa, polypoid lesions, and ulcers,
06Decreasing the size of inflamed areas, infiltration into the mucosa propria, and dependence and dosage of corticosteroids and medication,
07Shifting macrophage functional phenotype from M1 (protect) to M2 (repair), and
08Repairing the epithelial barrier.

Interested?

Talk to Your Primary Doctor First

They're pros who can give you personalized advice and recommend the latest treatment options that suit your unique condition.

One Size Does Not Fit All

Our doctors decide how many wjMSCs, the transfusion method, and the rounds of treatment that you need based on your medical records. So, be sure to send them to your patient liaison.

Research Findings

Multiple universities and institutions from across the globe have examined the efficacy of using wjMSCs to treat inflammatory bowel disease and reported promising outcomes.

Affiliated Drum Tower Hospital of Nanjing University Medical School, China
Decreased diarrhoea frequency and abdominal pain; significantly decreased Crohn's disease activity index, colitis activity index, endoscopic activity index, rough mucosa, and polypoid lesions ulcers, the extent of the inflamed area, and infiltration into the mucosa propria.
City of Hope National Medical Center, United States
Successfully controlled Crohn's disease in the long term.
University of Freiburg, Germany
Complete clinical, endoscopic, and histological remission, with initial aphthous lesions with minimal histological signs of inflammation.
Northwestern University Medical Center, United States
Improved symptoms, Crohn's disease activity index, and radiographic and colonoscopy findings. Eleven of the 12 patients achieved sustained remission.
Sacco University Hospital, Italy
Achieved clinical and endoscopic remission in all patients. Complete fistula closure was also observed.
Freiburg University Hospital, Germany
Improved clinical and endoscopic measures, and achieved remission.
Università degli Studi di Pavia, Italy
Sustained complete and incomplete fistula closure, decreased Crohn's disease and perianal disease activity indices, and significantly increased rectal mucosal healing.
Leiden University Medical Center, The Netherlands
Closed fistulas at Week 24 and remained closed four years later.
Mount Sinai School of Medicine, United States
Decreased Crohn's disease activity index and some achieved remission.
Autonomous University of Madrid, Spain
Good closure of rectovaginal fistula.
La Paz University Hospital, Spain
Healed fistulas in eight weeks.

What Makes Us Different?

Premium grade passage 2 wjMSCs

Our premium grade passage 2 wjMSCs are ethically derived from the umbilical cord tissues of healthy human babies that have been delivered after 37 weeks of gestation.

cGMP & ISO 9001 certified

Our laboratory is not only current goods & manufacturing practices (cGMP) certified, but ISO 9001 certified as well, both of which are internationally recognised standards for quality management systems (QMS).

Crafters of high-quality products

Our bio-safety level (BSL) 2 laboratory adheres to international standard operating procedures to ensure cleanliness and sterility as well as the safety of the environment.

Patient journey for international patients

Enquire now

The Patient Liaison that you are assigned will require your medical information. To streamline the process, either send your existing medical records to your Patient Liaison or get a medical test done in your country of residence and send it to your Patient Liaison.

Planning your treatment

Your Patient Liaison will send your medical reports to our doctors, who will tailor a personalised treatment plan for you or request that you get more medical tests done in your country of residence and send it to your Patient Liaison.

Ready to begin?

Once you've agreed to the treatment plan, let your Patient Liaison know when you'd like to start your treatment. They'll coordinate with our doctors and book a treatment slot for you.

Secure your spot

Let your Patient Liaison know how many people will be accompanying you to Malaysia and if you have any special requirements, such as ambulance or wheelchair assistance. You'll need to pay a deposit depending on the duration of your treatment, number of travellers, and special needs so that your Patient Liaison may make appropriate hotel bookings and transport arrangements.

Visas made easy

Visit the Immigration Department of Malaysia's website to check if you need a visa to enter the country. You may apply for an electronic visa (eVisa) here. Let your Patient Liaison know if you require an Invitation Letter and they'll send you one.

Book your flight tickets

When booking your flight tickets, it's recommended to arrive two days before your treatment date and to depart the day after your treatment ends.

Malaysia Digital Arrival Card (MDAC) registration

Two days before your arrival in Malaysia, go to this link to register yourself and all other travellers.

Arrival & airport transfer

Your Patient Liaison will organise your airport transfer to the hotel and send you your driver's contact details via email. Log in to "Airport WiFi" to check your email once you've landed at KLIA and contact your driver.

Check-in & pay for treatment

Your Patient Liaison will meet you at the hotel and help you check-in. You will be required to pay the remainder of your treatment fee in order for the laboratory to begin preparing the products for your treatment, which will be two days later. We accept cash, online funds transfers, PayPal, and credit / debit cards (Visa, MasterCard, American Express, JCB, Union Pay).

Let the healing begin

Your Patient Liaison will arrange transportation to and from the treatment facility on the treatment date and walk you through the registration and discharge processes.

Show more

Hear from Our Patients

More than 200 people have chosen Cyrona, why not you?
Learn more about our

Inflammatory Bowel Disease

Therapy Programme
Captcha

Download our complimentary eBook!